Differential risk assessment in persons at risk of type 2 diabetes using urinary peptidomics.

Schork, Anja et al.·Metabolism: clinical and experimental·2025·

Quick Facts

Study Type

Not classified

Evidence

Not graded

Sample

Not reported

What This Study Found

Key Numbers

How They Did This

Why This Research Matters

What This Study Doesn't Tell Us

Trust & Context

Original Title:: Differential risk assessment in persons at risk of type 2 diabetes using urinary peptidomics.
Published In:: Metabolism: clinical and experimental, 167, 156174 (2025)
Authors:: Schork, Anja, Fritsche, Andreas, Schleicher, Erwin D, Peter, Andreas, Heni, Martin, Stefan, Norbert, von Schwartzenberg, Reiner Jumpertz, Guthoff, Martina, Mischak, Harald, Siwy, Justyna, Birkenfeld, Andreas L, Wagner, Robert
Database ID:: RPEP-13472

Evidence Hierarchy

Meta-Analysis / Systematic Review

Randomized Controlled Trial

Cohort / Case-Control

Cross-Sectional / ObservationalSnapshot without intervening

This study

Case Report / Animal Study

What do these levels mean? →

Cite This Study

RPEP-13472·https://rethinkpeptides.com/research/RPEP-13472

APA

Schork, Anja; Fritsche, Andreas; Schleicher, Erwin D; Peter, Andreas; Heni, Martin; Stefan, Norbert; von Schwartzenberg, Reiner Jumpertz; Guthoff, Martina; Mischak, Harald; Siwy, Justyna; Birkenfeld, Andreas L; Wagner, Robert. (2025). Differential risk assessment in persons at risk of type 2 diabetes using urinary peptidomics.. Metabolism: clinical and experimental, 167, 156174. https://doi.org/10.1016/j.metabol.2025.156174

MLA

Schork, Anja, et al. "Differential risk assessment in persons at risk of type 2 diabetes using urinary peptidomics.." Metabolism: clinical and experimental, 2025. https://doi.org/10.1016/j.metabol.2025.156174

RethinkPeptides

RethinkPeptides Research Database. "Differential risk assessment in persons at risk of type 2 di..." RPEP-13472. Retrieved from https://rethinkpeptides.com/research/schork-2025-differential-risk-assessment-in

Access the Original Study

View on PubMed View via DOI

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.

← Back to Research Database